Ventas, Inc. (VTR)
After hours:
| Previous close | 44.01 |
| Open | 43.90 |
| Bid | 43.16 x 1000 |
| Ask | 44.79 x 900 |
| Day's range | 42.50 - 44.32 |
| 52-week range | 35.33 - 63.46 |
| Volume | |
| Avg. volume | 2,156,058 |
| Market cap | 17.34B |
| Beta (5Y monthly) | 1.22 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.10 |
| Earnings date | 03 May 2023 - 08 May 2023 |
| Forward dividend & yield | 1.80 (4.09%) |
| Ex-dividend date | 31 Mar 2023 |
| 1y target est | 53.12 |
- Business Wire
Ventas Announces Plans to Take Ownership of Full Collateral Pool Supporting its $486 Million Santerre Mezzanine Loan
CHICAGO, March 31, 2023--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced that it intends to take ownership of the collateral that supports its approximately $486 million cash-pay mezzanine loan to Santerre Health Investors (the "Santerre Mezzanine Loan"). The Santerre Mezzanine Loan is secured by equity interests in entities that collectively own a diverse pool of medical office buildings, senior housing operating portfolio communities, triple-net leased skilled nursing faci
- Business Wire
Ventas Declares First Quarter 2023 Dividend of $0.45 per Common Share
CHICAGO, March 14, 2023--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on April 13, 2023 to stockholders of record as of the close of business on April 3, 2023.
- Zacks
Is it Wise to Hold on to Healthpeak (PEAK) Stock for Now?
Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.
